论文部分内容阅读
美国FDA批准了默克公司研发的轮状病毒疫苗Ro- tateq。此疫苗是自1999年惠氏公司的同类产品Rota Shield遭到美国FDA否决后,现今美国市场上惟一用于预防轮状病毒性肠胃炎的疫苗。Rotateq须口服3次,用于6-32周的婴儿。本品使用方便,不须进行配制。
The U.S. FDA approved Ro- tateq, a rotavirus vaccine developed by Merck. This vaccine is the only vaccine currently available on the U.S. market for the prevention of rotavirus gastroenteritis since Rutgers’ Shield, a similar product from Wyeth, was vetoed by the U.S. FDA in 1999. Rotateq should be taken orally 3 times for infants from 6 to 32 weeks. This product is easy to use, do not need to be prepared.